BIOLASE Announces

Related by string. * BioLase . Biolase : BIOLASE TECHNOLOGY INC. CONSOLIDATED . BIOLASE principal . BIOLASE Technology Inc. . Biolase Technology Inc. . BioLase Technology . Biolase Technology / announc ed . ANNOUNCES . ANNOUNCE . announce . announces : Announces Second Quarter . Announces Third Quarter . Announces Fourth Quarter . Announce Partnership . Announces Launch . Announce Fourth Quarter * *

Related by context. Frequent words. (Click for all words.) 73 Updates Guidance 72 Provides Updates 71 Provides Guidance 71 Complete Merger 71 Regains Compliance 71 Previously Announced 71 3rd Quarter Results 70 Achieves Milestone 70 Updates Shareholders 70 Announces Enhancements 70 Completes Enrollment 70 Explore Strategic Alternatives 70 Forecast Quick Facts 69 Issues Guidance 69 FDA Clears 69 Option Grants 69 2nd Quarter Results 69 Guides FY# Quick Facts 69 1st Quarter Results 69 Q2 Loss Widens 69 Product Offerings 69 Annual Meeting Date 69 Q2 Loss Narrows 69 Announces Organizational Changes 68 Clinical Trial Results 68 Successful Completion 68 Subsidiary Receives 68 Q3 Loss Narrows 68 Vertex Pharmaceuticals Announces 68 Reaffirms Guidance 68 FY# Guidance 68 Guidance Quick Facts 68 Record Third Quarter 68 Momentum Continues 68 Record Second Quarter 68 美 通 社 68 Announces Initiation 68 CFO Resigns 68 Receives FDA Clearance 68 Completes Tender Offer 67 Further Strengthens 67 Q3 Loss Widens 67 Revenues Decline 67 Announces Signing 67 Q1 Loss Widens 67 Q4 Loss Narrows 67 Extends Tender Offer 67 Announces Publication 67 Lowers Guidance 67 Share Repurchases 67 Provides Comprehensive 67 Announces Termination 67 Subsidiary Signs 67 Q1 Loss Narrows 67 Analyst Upgrade 67 Shareholders Approve Merger 66 Q4 Loss Widens 66 Files Annual Report 66 Announces Shareholder Approval 66 Net Loss Narrows 66 Provides Preliminary 66 Drug Candidate 66 YORKNY 66 Commences Trading 66 Introduces Next Generation 66 Guides FY# 66 Preliminary Fourth Quarter 66 Announce Completion 66 Host Webcast 66 Phase III Clinical Trial 66 Patient Enrollment 66 Guides Q2 66 Narrows Loss 66 Releases Latest 66 MITTEILUNG UEBERMITTELT VON BUSINESS 66 Commence Trading 66 Guides Q4 66 Achieves Record 66 Announces Additions 66 Fiscal Second Quarter 66 Report Analyzes 66 Preclinical Data 66 Upcoming Conferences 66 Below Consensus 66 Extends Offer 66 Posts Strong 66 Receives Positive 66 #.#/Share [002] 66 Announces Intent 66 Updates Status 66 Shareholder Vote 66 Acquire Assets 66 Reports Profitable 66 Significant Increase 66 Provide Comprehensive 65 Releases Third Quarter 65 Reduces Risk 65 Announces Revised 65 Announces Intention 65 Presents Positive 65 FCC Approves

Back to home page